Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Henrik Hasman"'
Autor:
Mette Voldby Larsen, Henrik Hasman, Morten Nielsen, Ryszard Międzybrodzki, Ewa Jończyk-Matysiak, Henrik Westh, Henrike Zschach, Beata Weber-Dąbrowska, Andrzej Górski
Publikováno v:
Antibiotics; Volume 7; Issue 1; Pages: 9
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Antibiotics, Vol 7, Iss 1, p 9 (2018)
Zschach, H, Larsen, M V, Hasman, H, Westh, H, Nielsen, M, Międzybrodzki, R, Jónczyk-Matysiak, E, Weber-Dąbrowska, B & Górski, A 2018, ' Use of a regression model to study host-genomic determinants of phage susceptibility in MRSA ', Antibiotics, vol. 7, no. 1, 9 . https://doi.org/10.3390/antibiotics7010009
BASE-Bielefeld Academic Search Engine
Zschach, H, Larsen, M V, Hasman, H, Westh, H, Nielsen, M, Międzybrodzki, R, Jończyk-Matysiak, E, Weber-Dąbrowska, B & Górski, A 2018, ' Use of a Regression Model to Study Host-Genomic Determinants of Phage Susceptibility in MRSA ', The Journal of Antibiotics, vol. 7, no. 1 . https://doi.org/10.3390/antibiotics7010009
Antibiotics
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Antibiotics, Vol 7, Iss 1, p 9 (2018)
Zschach, H, Larsen, M V, Hasman, H, Westh, H, Nielsen, M, Międzybrodzki, R, Jónczyk-Matysiak, E, Weber-Dąbrowska, B & Górski, A 2018, ' Use of a regression model to study host-genomic determinants of phage susceptibility in MRSA ', Antibiotics, vol. 7, no. 1, 9 . https://doi.org/10.3390/antibiotics7010009
BASE-Bielefeld Academic Search Engine
Zschach, H, Larsen, M V, Hasman, H, Westh, H, Nielsen, M, Międzybrodzki, R, Jończyk-Matysiak, E, Weber-Dąbrowska, B & Górski, A 2018, ' Use of a Regression Model to Study Host-Genomic Determinants of Phage Susceptibility in MRSA ', The Journal of Antibiotics, vol. 7, no. 1 . https://doi.org/10.3390/antibiotics7010009
Antibiotics
Staphylococcus aureus is a major agent of nosocomial infections. Especially in methicillinresistant strains, conventional treatment options are limited and expensive, which has fueled a growing interest in phage therapy approaches. We have tested the